The FDA announced on Feb. 18, 2022, that NeuMoDx Molecular Inc is recalling NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems due to a potential for false positive SARS-CoV-2 results. The agency stated the hazard could lead to incorrect patient management.
How to tell if you have it
- Brand: NeuMoDx
- Product: NeuMoDx Cartridge-For in vitro diagnostic use with NeuMoOx Molecular Systems
- UPC: 10814278020274
- Lot Numbers: 115424, 115425, 115426, 115427, 115429, 115431
- Assays: NeuMoDx SARS-CoV-2 Test Strip Cat #300800 and NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay Cat #300900
The hazard
The recall addresses the potential for false positive results for SARS-CoV-2 in identified lots of cartridges when used with specific assays. The FDA stated this error could result in incorrect management of patients.
Context
GovInfoNow's records show NeuMoDx Molecular Inc has issued five other recalls since May 4, 2021. Other recent recalls of similar products include NeuMoDx Cartridges: Incorrect Label May Cause False Positives in PCR Tests (May 24, 2023), NeuMoDx SARS-CoV-2 Test Strips: Lot Number Mismatch Risk (May 15, 2023), and NeuMoDx Flu A-B/RSV/SARS-CoV-2 Test Strips May Give False Negatives (May 13, 2022). Other recent recalls of similar products include Changchun Wancheng Bio-Electron UTI Test Strips Recall: False Results Risk Inappropriate Treatment (Nov. 22, 2025), Vivoo Test Strips Recall: False Results Risk Inappropriate Medical Care (Nov. 22, 2025), and Fujirebio Lumipulse G pTau 217 Cartridges May Give False Alzheimer's Test Results (Dec. 11, 2025).